Tsutomu Iwasa

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.7K citations · Full text

Chemotherapy Versus Placebo, Breast Oncology, Oncology +7

Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samples

Takayuki Iwamoto, Naoki Niikura, Rin Ogiya et al. · Scientific Reports · 2019 · 213 citations · Full text

Breast Oncology, Brain Metastases, Immunology +18

Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non–Small Cell Lung Cancer Cell Lines

Tsutomu Iwasa, Isamu Okamoto, Minoru Suzuki et al. · Clinical Cancer Research · 2008 · 152 citations

Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status

Yusaku Akashi, Isamu Okamoto, Tsutomu Iwasa et al. · British Journal of Cancer · 2008 · 101 citations · Full text

Antitumor Activity, Immunology, Immunotherapy +16

Comparison of immune microenvironments between primary tumors and brain metastases in patients with breast cancer

Rin Ogiya, Naoki Niikura, Nobue Kumaki et al. · Oncotarget · 2017 · 89 citations · Full text